Combined Effect of Plasma-Activated Water and Topotecan in Glioblastoma Cells

The increase in cancer diagnoses and cancer deaths, severe side effects of existing treatments and resistance to traditional treatments have generated a need for new anticancer treatments. Glioblastoma multiforme (GBM) is the most common, malignant and aggressive brain cancer. Despite many innovatio...

Full description

Bibliographic Details
Main Authors: Beatriz Pinheiro Lopes, Liam O’Neill, Paula Bourke, Daniela Boehm
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/19/4858
_version_ 1797576145015668736
author Beatriz Pinheiro Lopes
Liam O’Neill
Paula Bourke
Daniela Boehm
author_facet Beatriz Pinheiro Lopes
Liam O’Neill
Paula Bourke
Daniela Boehm
author_sort Beatriz Pinheiro Lopes
collection DOAJ
description The increase in cancer diagnoses and cancer deaths, severe side effects of existing treatments and resistance to traditional treatments have generated a need for new anticancer treatments. Glioblastoma multiforme (GBM) is the most common, malignant and aggressive brain cancer. Despite many innovations regarding GBM treatment, the final outcome is still very poor, making it necessary to develop new therapeutic approaches. Cold atmospheric plasma (CAP) as well as plasma-activated liquids (PAL) are being studied as new possible approaches against cancer. The anticancer activity of PAL such as “plasma-activated water” (PAW) is dependent on the reactive chemical compounds present in the solution. Possible combinatory effects with conventional therapies, such as chemotherapeutics, may expand the potential of PAL for cancer treatment. We aim to explore the therapeutic properties of a combination of PAW and topotecan (TPT), an antineoplastic agent with major cytotoxic effects during the S phase of the cell cycle, on a GBM cancer cell line (U-251mg). Combined treatments with PAW and TPT showed a reduction in the metabolic activity and cell mass, an increase in apoptotic cell death and a reduction in the long-term survival. Single applications of PAW+TPT treatments showed a cytotoxic effect in the short term and an antiproliferative effect in the long term, warranting future exploration of combining PAW with chemotherapeutic agents as new therapeutic approaches.
first_indexed 2024-03-10T21:48:06Z
format Article
id doaj.art-e0cf2c6ce17245dcb421152789acab44
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T21:48:06Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-e0cf2c6ce17245dcb421152789acab442023-11-19T14:11:35ZengMDPI AGCancers2072-66942023-10-011519485810.3390/cancers15194858Combined Effect of Plasma-Activated Water and Topotecan in Glioblastoma CellsBeatriz Pinheiro Lopes0Liam O’Neill1Paula Bourke2Daniela Boehm3School of Chemical and Bioprocess Engineering, University College Dublin, D04 V1W8 Dublin, IrelandTheraDep Ltd., QUESTUM Innovation Centre, Limerick Institute of Technology, E91 V329 Clonmel, IrelandEnvironmental Sustainability and Health Institute and School of Food Science and Environmental Health, Technological University Dublin, D07 H6K8 Dublin, IrelandSchool of Chemical and Bioprocess Engineering, University College Dublin, D04 V1W8 Dublin, IrelandThe increase in cancer diagnoses and cancer deaths, severe side effects of existing treatments and resistance to traditional treatments have generated a need for new anticancer treatments. Glioblastoma multiforme (GBM) is the most common, malignant and aggressive brain cancer. Despite many innovations regarding GBM treatment, the final outcome is still very poor, making it necessary to develop new therapeutic approaches. Cold atmospheric plasma (CAP) as well as plasma-activated liquids (PAL) are being studied as new possible approaches against cancer. The anticancer activity of PAL such as “plasma-activated water” (PAW) is dependent on the reactive chemical compounds present in the solution. Possible combinatory effects with conventional therapies, such as chemotherapeutics, may expand the potential of PAL for cancer treatment. We aim to explore the therapeutic properties of a combination of PAW and topotecan (TPT), an antineoplastic agent with major cytotoxic effects during the S phase of the cell cycle, on a GBM cancer cell line (U-251mg). Combined treatments with PAW and TPT showed a reduction in the metabolic activity and cell mass, an increase in apoptotic cell death and a reduction in the long-term survival. Single applications of PAW+TPT treatments showed a cytotoxic effect in the short term and an antiproliferative effect in the long term, warranting future exploration of combining PAW with chemotherapeutic agents as new therapeutic approaches.https://www.mdpi.com/2072-6694/15/19/4858glioblastomaanticancer treatmentplasma-activated waterreactive speciestopotecancombination treatments
spellingShingle Beatriz Pinheiro Lopes
Liam O’Neill
Paula Bourke
Daniela Boehm
Combined Effect of Plasma-Activated Water and Topotecan in Glioblastoma Cells
Cancers
glioblastoma
anticancer treatment
plasma-activated water
reactive species
topotecan
combination treatments
title Combined Effect of Plasma-Activated Water and Topotecan in Glioblastoma Cells
title_full Combined Effect of Plasma-Activated Water and Topotecan in Glioblastoma Cells
title_fullStr Combined Effect of Plasma-Activated Water and Topotecan in Glioblastoma Cells
title_full_unstemmed Combined Effect of Plasma-Activated Water and Topotecan in Glioblastoma Cells
title_short Combined Effect of Plasma-Activated Water and Topotecan in Glioblastoma Cells
title_sort combined effect of plasma activated water and topotecan in glioblastoma cells
topic glioblastoma
anticancer treatment
plasma-activated water
reactive species
topotecan
combination treatments
url https://www.mdpi.com/2072-6694/15/19/4858
work_keys_str_mv AT beatrizpinheirolopes combinedeffectofplasmaactivatedwaterandtopotecaninglioblastomacells
AT liamoneill combinedeffectofplasmaactivatedwaterandtopotecaninglioblastomacells
AT paulabourke combinedeffectofplasmaactivatedwaterandtopotecaninglioblastomacells
AT danielaboehm combinedeffectofplasmaactivatedwaterandtopotecaninglioblastomacells